Business
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Mylan’"
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
World News
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Business
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
Business
The Perrigo stock weight in the TA-25 (derivatives) is 9.8%, second only to TEVA (10.5%).
Business
It's tictoc, tictoc, for Teva.
Court
– Teva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex Capsules. – – Teva Pharmaceutical Industries...
Court
– Teva sees the court preventing Mylan from launching its generic version of the Parkinson’s treatment before 2017. – – Teva Pharmaceutical Industries Ltd....
Court
– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through...